Loading clinical trials...
Loading clinical trials...
A Postmarketing Observational Cohort Study to Evaluate Effectiveness and Safety of Ponatinib (Iclusig®) in Patients With BCR-ABL Positive ALL in Standard Clinical Practice in Europe - "POSEIDON"
Conditions
Locations
10
Czechia
Ihbt/Úhkt
Prague, Czechia
University Hospital Amiens
Amiens, France
University Hospital Angers
Angers, France
University Hospital Bordeaux
Bordeaux, France
University Hospital Grenoble
Grenoble, France
University Hospital Lyon
Lyon, France
Start Date
December 31, 2018
Primary Completion Date
March 1, 2021
Completion Date
March 1, 2021
Last Updated
December 14, 2018
Lead Sponsor
Incyte Biosciences International Sàrl
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions